ARCHIVES

In This Issue: Congressional Testimony On NIH, NCI Appropriations, FDA Reform

This article is from The Cancer Letter archive.

Vol. 23 No. 18 | May 9, 1997

Download PDF Visit The Full Archive

Related Articles

NCI To Require Reports On Adverse Drug Reactions From Trials

June 10, 1994

In Brief: Obey Was Right- Tests On 70 Chemical Would Have Been Aborted Under NCI Budget

July 20, 1979

NCI To Offer Expanded Access To Oxaliplatin

May 31, 2002

Obituaries: Sylvan Green, Donald Gleason

January 23, 2009

In Congress: Societies, Advocates, Testify For Increases In Research Funding

February 13, 1998

NIH To Fund Fewer Grants This Year, But Reduce Cuts to Individual Awards.

February 8, 2008